Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for the treatment of visual hallucination associated with Parkinson's disease
TCTR20181220008Recruiting
- Sponsor
- Research and Development Center
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of gabapentin in Visual hallucination (VH) and Parkinson's disease (PD), sponsored by Research and Development Center. Started Jan 2019; status: recruiting.
02
Drugs
gabapentin
03
Conditions
Visual hallucination (VH)Parkinson's disease (PD)
Beyond the preview
Go deeper on TCTR20181220008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181220008.